安翰科技(武汉)股份有限公司

公司简介     安翰公司专业从事医疗器械研发、生产、销售及服务，拥有控制和成像多项专利，实现对胃部全面精确检查。目前，安翰的主动控制技术在国际上尚无其他医疗企业能够与之比肩。     NaviCamTM 胶囊内镜机器人系统（简称“胶囊胃镜”）是我国完全自主研发、世界首台可主动精确控制的胶囊胃镜。被医学界誉为“21世纪胃疾病检查和内镜发展的革命性创新”。同时，也是国家“十二五”医疗科技创新的一项重要成果。安翰胶囊胃镜2013年1月经CFDA批准上市，具有无创、无痛、不麻醉及高精准度特性，可以为更广泛人群进行胃镜检查，是胃部疾病早期检查利器，提高早癌检出率。目前已经在全国400余家医院及体检中心投入使用。 简历接收邮箱：hr@***@*** 有意应聘者将个人简历电邮至本公司人力资源部收（标明“应聘职位+姓名”）。 Specializing in medical equipment R&D, production, sales and services, ANKON Technologies Co., Ltd. (ANKON) has successfully developed and commercialized the world’s first magnetically controlled capsule endoscope system. Today, many of the first experts identified by the Organization Department of the CPC Central Committee for the 1,000 Plan and excellent PhDs from the Silicon Valley are working at ANKON. With patented control and imaging technologies, we are able to provide comprehensive, accurate gastric examinations, making us unrivaled in the industry. Characterized by a painless, non-invasive, anesthesia-free experience and high accuracy, NaviCam magnetically controlled capsule endoscope system (NaviCam) is able to provide more consumers with examinations. With a higher early cancer detection rate, it is a great tool for early gastric disease screening. A large number of Chinese digestive endoscopy specialists and physicians are now working for the online ANKON 120 platform(www.ankon120.com), which enables remote film reading and thus makes it possible to conduct gastroscopy in areas with insufficient medical resources. This platform is also significant for assessing the effects of gastrointestinal medications and for evidence-based medical research. Today ANKON has grown to over 400 employees worldwide with products used by over 400 hospitals and clinics. ANKON has obtained or applied more than 50 China, US and international patents. ANKON has received attention from numerous CPC and state leaders, including visits by Hu Jintao, the former Chinese President, in 2011 and Xi Jinping, the incumben